Initial proof-of-concept and dose-finding experiments were done using non-tumor-bearing mice to see whether PSMA-mediated SG of [18F]DCFPyL can be blocked at all by DCFPyL given either systemically (SYS study group) or locally via retrograde cannulation (CAN study group). The gene discussed is FOLH1; the disease is neoplasm.